Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate and Severe RheumatoId Arthritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02720523
What this trial is testing

Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and Have an Inadequate Response to csDMARDs

Who this might be right for
Rheumatoid Arthritis
AbbVie 197
Testing effectiveness (Phase 2)Active Not RecruitingNCT06041269
What this trial is testing

Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR)

Who this might be right for
Rheumatoid Arthritis
AnaptysBio, Inc. 420
Testing effectiveness (Phase 2)Ended earlyNCT00083759
What this trial is testing

Natalizumab in the Treatment of Rheumatoid Arthritis in Subjects Receiving Methotrexate

Who this might be right for
Rheumatoid Arthritis
Biogen 299
Large-scale testing (Phase 3)Study completedNCT01649804
What this trial is testing

A Long-Term Safety Extension Study of WA19926 in Participants With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 12
Large-scale testing (Phase 3)Study completedNCT02760433
What this trial is testing

Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease

Who this might be right for
Rheumatoid Arthritis
R-Pharm International, LLC 368
Testing effectiveness (Phase 2)Study completedNCT03618784
What this trial is testing

Safety and Efficacy of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Kang Stem Biotech Co., Ltd. 33
Large-scale testing (Phase 3)Study completedNCT02792699
What this trial is testing

Study to Assess if ABP 798 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis (RA) Compared to Rituximab

Who this might be right for
Arthritis, Rheumatoid
Amgen 311
Testing effectiveness (Phase 2)Study completedNCT01373151
What this trial is testing

Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate

Who this might be right for
Rheumatoid Arthritis
CSL Behring 418
Large-scale testing (Phase 3)Active Not RecruitingNCT02629159
What this trial is testing

A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
AbbVie 1,629
Not applicableStudy completedNCT04497597
What this trial is testing

Oral Upadacitinib Tablets to Assess Treatment Patterns, Achievement of Treatment Targets and Maintenance of Response in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 1,532
Testing effectiveness (Phase 2)Study completedNCT01565655
What this trial is testing

Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Astellas Pharma Global Development, Inc. 289
Large-scale testing (Phase 3)Study completedNCT03052322
What this trial is testing

MSB11022 in Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Moderate to Severe Rheumatoid Arthritis
Fresenius Kabi SwissBioSim GmbH 288
Large-scale testing (Phase 3)Study completedNCT02760407
What this trial is testing

Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease

Who this might be right for
Rheumatoid Arthritis
R-Pharm International, LLC 1,648
Testing effectiveness (Phase 2)UnknownNCT01408602
What this trial is testing

Two Doses of MRC375 in Moderate to Severe Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Molecular Research Center, Inc. 300
Large-scale testing (Phase 3)Study completedNCT00025818
What this trial is testing

Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome

Who this might be right for
Keratoconjunctivitis SiccaSjogren's SyndromeLupus Erythematosus, Systemic+2 more
Allergan 290
Early research (Phase 1)Active Not RecruitingNCT06175338
What this trial is testing

Study, Evaluating Pharmacokinetics, Pharmacodynamics, Immunogenicity and Safety Profiles of Rituximab Compared to MabThera® in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Mabscale, LLC 208
Large-scale testing (Phase 3)Study completedNCT00106548
What this trial is testing

Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 623
Large-scale testing (Phase 3)Study completedNCT03478111
What this trial is testing

CMAB008 With MTX Therapy in Adult Patients With Moderately to Severely Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Shanghai Biomabs Pharmaceutical Co., Ltd. 390
Testing effectiveness (Phase 2)Looking for participantsNCT07276581
What this trial is testing

Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
AstraZeneca 320
Not applicableStudy completedNCT05170646
What this trial is testing

An Observational Study to Assess the Real-World Effectiveness of Upadacitinib in Adult Participants With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
AbbVie 97
Next Page